A newly developed blood test could help doctors rule out cancer in patients presenting certain symptoms, helping avoid the expense and stress of undergoing unnecessary and invasive procedures like colonoscopies and biopsies. Called Lymphocyte Genome Sensitivity (LGS) test, the analysis hones in on the DNA of white blood cells.

READ FULL ARTICLE Curated publisher From UPI.com